Clinical Trial Update: Scaling and Root Planning With Localized Delivery of Autogenous Growth Factors- Platelet Rich Fibrin (PRF) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating localized autogenous growth factors via Platelet Rich Fibrin for periodontitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis Chronic Generalized Moderate
• Periodontitis Chronic Generalized Severe

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Periodontitis Chronic Generalized Severe, Periodontitis Chronic Generalized Moderate | Phase 3 | Status: WITHDRAWN